140 related articles for article (PubMed ID: 22399627)
1. Phase II study of panobinostat and bortezomib in patients with pancreatic cancer progressing on gemcitabine-based therapy.
Wang H; Cao Q; Dudek AZ
Anticancer Res; 2012 Mar; 32(3):1027-31. PubMed ID: 22399627
[TBL] [Abstract][Full Text] [Related]
2. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, dou
